Ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate

Catalog No. :
ACKGOM133
CAS No. :
1620205-04-0
Molecular Formula :
C17H16ClN3O5
Molecular Weight :
377.78

IUPAC Name:ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate

Ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate
IUPAC Nameethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate
Molecular FormulaC17H16ClN3O5
Molecular Weight377.78
SMILESCCOC(=O)CCN(C(=O)C1=CC=C(Cl)C([N+](=O)[O-])=C1)C1=NC=CC=C1
InChI KeySHDPKXGBOOZZAP-UHFFFAOYSA-N
Synonym3-[(4-chloro-3-nitrobenzoyl)pyridin-2-yl-amino]propionic acid ethyl ester;ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate;β-Alanine, N-(4-chloro-3-nitrobenzoyl)-N-2-pyridinyl-, ethyl ester
CAS No.1620205-04-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKGOM133 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGUKE379 route compound structure diagram
    ACGUKE379103041-38-9 In Stock
  2. Plus
  3. ACEQGH075 route compound structure diagram
    ACEQGH07538818-50-7 In Stock
  4. Then
  5. ACKGOM133 route product structure diagram
    ACKGOM1331620205-04-0
Inquiry

2. ACKGOM133 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGNZJ571 route compound structure diagram
    ACGNZJ571539-74-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKGOM133 route product structure diagram
    ACKGOM1331620205-04-0
Inquiry

Comments (0)